Aktie A043220 TS NEXGEN CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen TS Nexgen Co., Ltd.

Aktien

A043220

KR7043220003

A043220

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 24.06.2024 		% 5 Tage % 1. Jan.
522 KRW -0,57 % Intraday Chart für TS Nexgen Co., Ltd. -24,24 % -16,35 %
16.05. TS Nexgen Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
20.03. TS Nexgen Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
TS Nexgen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
TS Nexgen Co., Ltd. announced that it has received KRW 6.05 billion in funding from SU-Holdings Co.,Ltd.
TS Nexgen Co., Ltd. announced that it expects to receive KRW 6.05 billion in funding from SU-Holdings Co.,Ltd.
TS Nexgen Co., Ltd. agreed to acquire 73.43% stake in Neurosona Co., Ltd. from SU-Holdings Co.,Ltd. for KRW 6.05 billion.
TS Nexgen Co., Ltd. announced that it has received KRW 6.499999498 billion in funding
TS Nexgen Co., Ltd. announced that it expects to receive KRW 19 billion in funding from Sangsangin Savings Bank
TS Nexgen Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
TS Nexgen Co., Ltd. announced that it expects to receive KRW 7.99999998 billion in funding
TS Nexgen Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
TS Nexgen Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
TS Nexgen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
TS Nexgen Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
TS Nexgen Co., Ltd. agreed to acquire remaining 48.74% stake in TS CellMedi Co., Ltd. for KRW 2,636.7 million.
TS Nexgen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
TS Nexgen Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
TS Nexgen Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd.
HLB Power Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Ts Bio Co., Ltd. and Cho Yong-jun completed the acquisition of 9.62% stake in HLB Power Co., Ltd. from Jin Yang Gon and Lee Hyun Soo.
Ts Bio Co., Ltd. and Cho Yong-jun Concluded a share transfer contract to acquire 9.62% stake in HLB Power Co., Ltd. from Jin Yang Gon and Lee Hyun Soo for KRW 26.3 billion.
HLB Power Co., Ltd. announced that it has received KRW 33 billion in funding from JJ Assets Co., Ltd. and other investors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A043220 Aktie
  4. Nachrichten TS Nexgen Co., Ltd.
  5. Andere Sprachen